252 filings
8-K
INCY
Incyte Corp.
13 May 24
Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock
7:18am
8-K
INCY
Incyte Corp.
30 Apr 24
Incyte Reports 2024 First Quarter Financial Results and Provides Updates
7:10am
8-K
INCY
Incyte Corp.
13 Feb 24
Provides 2024 Financial Guidance and Highlights R&D Priorities
7:03am
8-K
INCY
Incyte Corp.
31 Oct 23
Incyte Reports 2023 Third Quarter Financial Results and Provides Updates
7:05am
8-K
INCY
Incyte Corp.
12 Sep 23
Departure of Directors or Certain Officers
5:00pm
8-K
bul0wib7mt
1 Aug 23
Incyte Reports 2023 Second Quarter Financial Results and Provides Updates
7:05am
8-K
0g5y895ni
15 Jun 23
Departure of Directors or Certain Officers
2:10pm
8-K
tndio430hx zr
8 May 23
Other Events
5:21pm
8-K
27iot03 9j5
2 May 23
Incyte Reports 2023 First Quarter Financial Results and Provides Updates on Key Clinical Programs
7:01am
8-K
syf0 upfeidj6
7 Feb 23
Provides 2023 Financial Guidance and Updates on Key Clinical Programs
7:05am
8-K
azi cpjbg5d6
1 Nov 22
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key
7:05am
8-K
4t7d9se8ca2ks4
4 Oct 22
Departure of Directors or Certain Officers
7:30am
8-K
j9s t22cnd892pl
2 Aug 22
Incyte Reports 2022 Second Quarter Financial Results and Provides Updates on Key
7:25am
8-K
spin9edfxq11qn 4m5
16 Jun 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
tff1d7 0yw
3 May 22
Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key
7:16am
8-K
eanm01xv
21 Apr 22
Departure of Directors or Certain Officers
8:21am
8-K
2hbgwv2ne
8 Feb 22
Incyte Reports 2021 Fourth Quarter and Year-end Financial Results, and Provides 2022 Financial Guidance and Updates on Key Clinical Programs
7:17am
8-K
uj4qynsf3 2x
14 Jan 22
Departure of Directors or Certain Officers
4:09pm
8-K
psza oye8c2
2 Nov 21
Corporate Statement Regarding Opzeluraâ„¢ (ruxolitinib) Cream
4:50pm
8-K
0v1xw5n1y nhm4jviok
2 Nov 21
Incyte Reports 2021 Third Quarter Financial Results
7:15am